combination therapy with glp-1 receptor agonist and sglt2 inhibitor

combination therapy with glp-1 receptor agonist and sglt2 inhibitor Agonists as Treatments for Type 2 Diabetes Assessing the proportion of patients

Name: combination therapy with glp-1 receptor agonist and sglt2 inhibitor Agonists as Treatments for Type 2 Diabetes Assessing the proportion of patients
Brand: actil.am
SKU: 64293209642
Price: 21.75 USD
Availability: InStock
Rating: 4.0828 (24 reviews)

SKU: 64293209642

4.1

USD21.75 USD68.75

Pay in 4 interest-free payments of $5.44 Learn more

Shipping Estimate
USA

USA

CAN

Ships within 48 hours · Estimated delivery Aug 27 - Sep 1

Description

Demand Drivers Prevalence of Type 2 Diabetes and Obesity: The increasing global prevalence of type 2 diabetes and obesity drives the demand for GLP-1 receptor agonists as effective treatment options

Vert G, Grotz N, Ddaldchamp F, Gaymard F, Guerinot ML, Briat JF, Curie C (2002) IRT1, an Arabidopsis transporter essential for iron uptake from the soil and for plant growth

Network pharmacology-based study on the mechanism of ShenKang injection in diabetic kidney disease through Keap1/Nrf2/Ho-1 signaling pathway